3D Bioprinting Market Research Report – forecast till 2028

3D Bioprinting Market Research Report: By Technology (Microextrusion Bioprinting, Inkjet 3D Bioprinting, Laser-assisted Bioprinting, Magnetic 3D Bioprinting), By Material (Living Cells, Hydrogels, Extracellular Matrices), By Application (Research Applications, Clinical Applications), By End-user (Pharmaceutical & Biotechnology Companies, Research Organizations & Academic Institutes) - Forecast till 2028

ID: MRFR/MED/0367-CR | February 2021 | Region: Global | 163 Pages         

1 Report Prologue

2 Executive Summary

3 Market Introduction

3.1 Definition 20

3.2 Scope of the Study 20

3.3 Research Objective 20

3.4 Assumptions & Limitations 20

3.4.1 Assumptions 20

3.4.2 Limitations 20

3.5 Market Structure 21

3.6 Research Process 21

4 Research Methodology

4.1 Primary Research 24

4.2 Secondary Research 25

4.3 Market Size Estimation 26

4.4 Forecast Model 26

5 Market Dynamics

5.1 Introduction 28

5.2 Drivers 28

5.2.1 Growing Demand for Organ Transplantation 28

5.2.2 Cost-Efficiency of 3D Bioprinting 28

5.2.3 Growing Focus of Market Players on 3D Bioprinting 29

5.2.4 Increasing Funding and Investments for Research 29

5.3 Restraints 29

5.3.1 Lack of Awareness Regarding 3D Bioprinting 29

5.3.2 Lack of Skilled Professionals 29

5.4 Opportunities 30

5.4.1 Dominance of Start-Ups 30

6 Market Factor Analysis

6.1 Porter’s Five Forces Model 32

6.1.1 Bargaining Power of Suppliers 32

6.1.2 Bargaining Power of Buyers 33

6.1.3 Threat of New Entrants 33

6.1.4 Threat of Substitutes 33

6.1.5 Rivalry 33

6.2 Supply Chain Analysis 34

6.2.1 R&D and Development 34

6.2.2 Manufacturing 34

6.2.3 Distribution & Sales 34

6.2.4 Post-Sales Monitoring 35

6.3 Investment Feasibility Analysis 35

6.4 Pricing Analysis 35

7 3D Bioprinting Market, by Technology

7.1 Introduction 37

7.2 Microextrusion Bioprinting 38

7.3 Inkjet 3D bioprinting 39

7.4 Laser-Assisted Bioprinting 39

7.5 Magnetic 3D Bioprinting 40

8 3D Bioprinting Market, by Material

8.1 Introduction 42

8.2 Living Cells 43

8.3 Hydrogels 44

8.4 Extracellular Matrices 44

9 3D Bioprinting Market, by Application

9.1 Introduction 47

9.2 Research Applications 48

9.3 Clinical Applications 51

10 3D Bioprinting Market, by End User

10.1 Introduction 54

10.2 Pharmaceutical & Biotechnology Companies 55

10.3 Research Organizations & Academic Institutes 56

11 Global 3D Bioprinting Market, by Region

11.1 Introduction 58

11.2 Americas 60

3D Bioprinting Market, by Technology

3D Bioprinting Market, by Material

3D Bioprinting Market, by Application

3D Bioprinting Market, by End User

11.2.1 North America 63

3D Bioprinting Market, by Technology

3D Bioprinting Market, by Material

3D Bioprinting Market, by Application

3D Bioprinting Market, by End User

11.2.1.1 US 67

3D Bioprinting Market, by Technology

3D Bioprinting Market, by Material

3D Bioprinting Market, by Application

3D Bioprinting Market, by End User

11.2.1.2 Canada 69

3D Bioprinting Market, by Technology

3D Bioprinting Market, by Material

3D Bioprinting Market, by Application

3D Bioprinting Market, by End User

11.2.2 South America 72

3D Bioprinting Market, by Technology

3D Bioprinting Market, by Material

3D Bioprinting Market, by Application

3D Bioprinting Market, by End User

11.3 Europe 75

3D Bioprinting Market, by Technology

3D Bioprinting Market, by Material

3D Bioprinting Market, by Application

3D Bioprinting Market, by End User

11.3.1 Western Europe 79

3D Bioprinting Market, by Technology

3D Bioprinting Market, by Material

3D Bioprinting Market, by Application

3D Bioprinting Market, by End User

11.3.1.1 Germany 83

3D Bioprinting Market, by Technology

3D Bioprinting Market, by Material

3D Bioprinting Market, by Application

3D Bioprinting Market, by End User

11.3.1.2 France 85

3D Bioprinting Market, by Technology

3D Bioprinting Market, by Material

3D Bioprinting Market, by Application

3D Bioprinting Market, by End User

11.3.1.3 U.K 88

3D Bioprinting Market, by Technology

3D Bioprinting Market, by Material

3D Bioprinting Market, by Application

3D Bioprinting Market, by End User

11.3.1.4 Italy 90

3D Bioprinting Market, by Technology

3D Bioprinting Market, by Material

3D Bioprinting Market, by Application

3D Bioprinting Market, by End User

11.3.1.5 Spain 93

3D Bioprinting Market, by Technology

3D Bioprinting Market, by Material

3D Bioprinting Market, by Application

3D Bioprinting Market, by End User

11.3.1.6 Rest of Western Europe 95

3D Bioprinting Market, by Technology

3D Bioprinting Market, by Material

3D Bioprinting Market, by Application

3D Bioprinting Market, by End User

11.3.2 Eastern Europe 98

3D Bioprinting Market, by Technology

3D Bioprinting Market, by Material

3D Bioprinting Market, by Application

3D Bioprinting Market, by End User

11.4 Asia-Pacific 101

3D Bioprinting Market, by Technology

3D Bioprinting Market, by Material

3D Bioprinting Market, by Application

3D Bioprinting Market, by End User

11.4.1 Japan 105

3D Bioprinting Market, by Technology

3D Bioprinting Market, by Material

3D Bioprinting Market, by Application

3D Bioprinting Market, by End User

11.4.2 China 108

3D Bioprinting Market, by Technology

3D Bioprinting Market, by Material

3D Bioprinting Market, by Application

3D Bioprinting Market, by End User

11.4.3 India 111

3D Bioprinting Market, by Technology

3D Bioprinting Market, by Material

3D Bioprinting Market, by Application

3D Bioprinting Market, by End User

11.4.4 Australia 114

3D Bioprinting Market, by Technology

3D Bioprinting Market, by Material

3D Bioprinting Market, by Application

3D Bioprinting Market, by End User

11.4.5 South Korea 116

3D Bioprinting Market, by Technology

3D Bioprinting Market, by Material

3D Bioprinting Market, by Application

3D Bioprinting Market, by End User

11.4.6 Rest of Asia–Pacific 119

3D Bioprinting Market, by Technology

3D Bioprinting Market, by Material

3D Bioprinting Market, by Application

3D Bioprinting Market, by End User

11.5 Middle East and Africa 122

3D Bioprinting Market, by Technology

3D Bioprinting Market, by Material

3D Bioprinting Market, by Application

3D Bioprinting Market, by End User

11.5.1 Middle East 126

3D Bioprinting Market, by Technology

3D Bioprinting Market, by Material

3D Bioprinting Market, by Application

3D Bioprinting Market, by End User

11.5.2 Africa 129

3D Bioprinting Market, by Technology

3D Bioprinting Market, by Material

3D Bioprinting Market, by Application

3D Bioprinting Market, by End User

12 Competitive Landscape

12.1 Introduction 133

12.2 Company Ranking 133

13 Company Profiles

13.1 Organovo Holdings Inc. 135

13.1.1 Company Overview 135

13.1.2 Financial Overview 135

13.1.3 Products/Services Offered 136

13.1.4 Key Developments 136

13.1.5 SWOT Analysis 136

13.1.6 Key Strategy 136

13.2 Cellink AB 137

13.2.1 Company Overview 137

13.2.2 Financial Overview 137

13.2.3 Products/Services Offered 138

13.2.4 Key Developments 138

13.2.5 SWOT Analysis 138

13.2.6 Key Strategy 139

13.3 Stratasys Ltd 140

13.3.1 Company Overview 140

13.3.2 Financial Overview 140

13.3.3 Products/Services Offered 141

13.3.4 Key Developments 141

13.3.5 SWOT Analysis 141

13.3.6 Key Strategy 141

13.4 FUJIFILM Wako Automation Corporation 142

13.4.1 Company Overview 142

13.4.2 Financial Overview 142

13.4.3 Products/Services Offered 143

13.4.4 Key Developments 143

13.4.5 SWOT Analysis 143

13.4.6 Key Strategy 143

13.5 Envisiontec GMBH 144

13.5.1 Company Overview 144

13.5.2 Financial Overview 144

13.5.3 Products/Services Offered 144

13.5.4 Key Developments 144

13.5.5 SWOT Analysis 145

13.5.6 Key Strategy 145

13.6 Nano3D Biosciences Inc. 146

13.6.1 Company Overview 146

13.6.2 Financial Overview 146

13.6.3 Products/Services Offered 146

13.6.4 Key Developments 146

13.6.5 SWOT Analysis 147

13.6.6 Key Strategy 147

13.7 Allevi 148

13.7.1 Company Overview 148

13.7.2 Financial Overview 148

13.7.3 Products/Services Offered 148

13.7.4 Key Developments 148

13.7.5 SWOT Analysis 149

13.7.6 Key Strategy 149

13.8 Cyfuse Biomedical K.K. 150

13.8.1 Company Overview 150

13.8.2 Financial Overview 150

13.8.3 Products/Services Offered 150

13.8.4 Key Developments 150

13.8.5 SWOT Analysis 150

13.8.6 Key Strategy 151

13.9 REGENHU LTD 152

13.9.1 Company Overview 152

13.9.2 Financial Overview 152

13.9.3 Products/Services Offered 152

13.9.4 Key Developments 152

13.9.5 SWOT Analysis 153

13.9.6 Key Strategy 153

13.10 Aspect Biosystems Ltd 154

13.10.1 Company Overview 154

13.10.2 Financial Overview 154

13.10.3 Products/Services Offered 154

13.10.4 Key Developments 154

13.10.5 SWOT Analysis 155

13.10.6 Key Strategy 155

13.11 Regenovo Biotechnology Co. Ltd. 156

13.11.1 Company Overview 156

13.11.2 Financial Overview 156

13.11.3 Products/Services Offered 156

13.11.4 Key Developments 156

13.11.5 SWOT Analysis 157

13.11.6 Key Strategy 157

13.12 Poietis 158

13.12.1 Company Overview 158

13.12.2 Financial Overview 158

13.12.3 Products/Services Offered 158

13.12.4 Key Developments 158

13.12.5 SWOT Analysis 159

13.12.6 Key Strategy 159

14 Appendix

14.1 Discussion Blue Print 161

15 List of Tables

TABLE 1 MARKET SYNOPSIS 18

TABLE 2 PRIMARY INTERVIEWS 22

TABLE 3 GLOBAL 3D BIOPRINTING MARKET BY TECHNOLOGY, 2020–2028 (USD MILLION) 38

TABLE 4 GLOBAL 3D BIOPRINTING MARKET FOR MICROEXTRUSION BIOPRINTING BY REGION, 2020–2028 (USD MILLION) 38

TABLE 5 GLOBAL 3D BIOPRINTING MARKET FOR INKJET 3D BIOPRINTING BY REGION, 2020–2028 (USD MILLION) 39

TABLE 6 GLOBAL 3D BIOPRINTING MARKET FOR LASER-ASSISTED BIOPRINTING BY REGION, 2020–2028 (USD MILLION) 40

TABLE 7 GLOBAL 3D BIOPRINTING MARKET FOR MAGNETIC 3D BIOPRINTING BY REGION, 2020–2028 (USD MILLION) 40

TABLE 8 GLOBAL 3D BIOPRINTING MARKET BY MATERIAL, 2020–2028 (USD MILLION) 43

TABLE 9 GLOBAL 3D BIOPRINTING MARKET FOR LIVING CELLS BY REGION, 2020–2028 (USD MILLION) 43

TABLE 10 GLOBAL 3D BIOPRINTING MARKET FOR HYDROGELS BY REGION, 2020–2028 (USD MILLION) 44

TABLE 11 GLOBAL 3D BIOPRINTING MARKET FOR EXTRACELLULAR MATRICES BY REGION, 2020–2028 (USD MILLION) 45

TABLE 12 GLOBAL 3D BIOPRINTING MARKET BY APPLICATION, 2020–2028 (USD MILLION) 47

TABLE 13 GLOBAL 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS BY TYPE, 2020–2028 (USD MILLION) 48

TABLE 14 GLOBAL 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2020–2028 (USD MILLION) 48

TABLE 15 GLOBAL 3D BIOPRINTING MARKET FOR RESEARCH APPLICATIONS BY REGION, 2020–2028 (USD MILLION) 49

TABLE 16 GLOBAL 3D BIOPRINTING MARKET FOR DRUG RESEARCH BY REGION, 2020–2028 (USD MILLION) 49

TABLE 17 GLOBAL 3D BIOPRINTING MARKET FOR REGENERATIVE MEDICINE & TISSUE ENGINEERING BY REGION, 2020–2028

(USD MILLION) 50

TABLE 18 GLOBAL 3D BIOPRINTING MARKET FOR 3D CELL CULTURE BY REGION, 2020–2028 (USD MILLION) 50

TABLE 19 GLOBAL 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY REGION, 2020–2028 (USD MILLION) 51

TABLE 20 GLOBAL 3D BIOPRINTING MARKET FOR SKIN BY REGION, 2020–2028 (USD MILLION) 51

TABLE 21 GLOBAL 3D BIOPRINTING MARKET FOR DENTAL BY REGION, 2020–2028 (USD MILLION) 52

TABLE 22 GLOBAL 3D BIOPRINTING MARKET FOR BONE BY REGION, 2020–2028 (USD MILLION) 52

TABLE 23 GLOBAL 3D BIOPRINTING MARKET BY END USER, 2020–2028 (USD MILLION) 55

TABLE 24 GLOBAL 3D BIOPRINTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2020–2028

(USD MILLION) 55

TABLE 25 GLOBAL 3D BIOPRINTING MARKET FOR RESEARCH ORGANIZATIONS & ACADEMIC INSTITUTES, BY REGION, 2020–2028

(USD MILLION) 56

TABLE 26 GLOBAL 3D BIOPRINTING MARKET, BY REGION, 2020–2028 (USD MILLION) 59

TABLE 27 AMERICAS: 3D BIOPRINTING MARKET, BY REGION, 2020–2028 (USD MILLION) 60

TABLE 28 AMERICAS: 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2020–2028 (USD MILLION) 61

TABLE 29 AMERICAS: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2028 (USD MILLION) 61

TABLE 30 AMERICAS: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 62

TABLE 31 AMERICAS: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATION BY TYPE, 2020–2028 (USD MILLION) 62

TABLE 32 AMERICAS: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2020–2028 (USD MILLION) 62

TABLE 33 AMERICAS: 3D BIOPRINTING MARKET, BY END USER, 2020–2028 (USD MILLION) 63

TABLE 34 NORTH AMERICA: 3D BIOPRINTING MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 64

TABLE 35 NORTH AMERICA: 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2020–2028 (USD MILLION) 64

TABLE 36 NORTH AMERICA: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2028 (USD MILLION) 65

TABLE 37 NORTH AMERICA: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 65

TABLE 38 NORTH AMERICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATION BY TYPE, 2020–2028 (USD MILLION) 65

TABLE 39 NORTH AMERICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2020–2028 (USD MILLION) 66

TABLE 40 NORTH AMERICA: 3D BIOPRINTING MARKET, BY END USER, 2020–2028 (USD MILLION) 66

TABLE 41 US: 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2020–2028 (USD MILLION) 67

TABLE 42 US: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2028 (USD MILLION) 67

TABLE 43 US: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 68

TABLE 44 US: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATION BY TYPE, 2020–2028 (USD MILLION) 68

TABLE 45 US: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2020–2028 (USD MILLION) 68

TABLE 46 US: 3D BIOPRINTING MARKET, BY END USER, 2020–2028 (USD MILLION) 69

TABLE 47 CANADA: 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2020–2028 (USD MILLION) 69

TABLE 48 CANADA: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2028 (USD MILLION) 70

TABLE 49 CANADA: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 70

TABLE 50 CANADA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATION BY TYPE, 2020–2028 (USD MILLION) 70

TABLE 51 CANADA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2020–2028 (USD MILLION) 71

TABLE 52 CANADA: 3D BIOPRINTING MARKET, BY END USER, 2020–2028 (USD MILLION) 71

TABLE 53 SOUTH AMERICA: 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2020–2028 (USD MILLION) 72

TABLE 54 SOUTH AMERICA: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2028 (USD MILLION) 72

TABLE 55 SOUTH AMERICA: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 73

TABLE 56 SOUTH AMERICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATION BY TYPE, 2020–2028 (USD MILLION) 73

TABLE 57 SOUTH AMERICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2020–2028 (USD MILLION) 73

TABLE 58 SOUTH AMERICA: 3D BIOPRINTING MARKET, BY END USER, 2020–2028 (USD MILLION) 74

TABLE 59 EUROPE: 3D BIOPRINTING MARKET, BY REGION, 2020–2028 (USD MILLION) 76

TABLE 60 EUROPE: 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2020–2028 (USD MILLION) 76

TABLE 61 EUROPE: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2028 (USD MILLION) 77

TABLE 62 EUROPE: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 77

TABLE 63 EUROPE: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATION BY TYPE, 2020–2028 (USD MILLION) 77

TABLE 64 EUROPE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2020–2028 (USD MILLION) 78

TABLE 65 EUROPE: 3D BIOPRINTING MARKET, BY END USER, 2020–2028 (USD MILLION) 78

TABLE 66 WESTERN EUROPE: 3D BIOPRINTING MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 79

TABLE 67 WESTERN EUROPE: 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2020–2028 (USD MILLION) 80

TABLE 68 WESTERN EUROPE: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2028 (USD MILLION) 80

TABLE 69 WESTERN EUROPE: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 81

TABLE 70 WESTERN EUROPE: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATION BY TYPE, 2020–2028 (USD MILLION) 81

TABLE 71 WESTERN EUROPE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2020–2028 (USD MILLION) 81

TABLE 72 WESTERN EUROPE: 3D BIOPRINTING MARKET, BY END USER, 2020–2028 (USD MILLION) 82

TABLE 73 GERMANY: 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2020–2028 (USD MILLION) 83

TABLE 74 GERMANY: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2028 (USD MILLION) 83

TABLE 75 GERMANY: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 84

TABLE 76 GERMANY: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATION BY TYPE, 2020–2028 (USD MILLION) 84

TABLE 77 GERMANY: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2020–2028 (USD MILLION) 84

TABLE 78 GERMANY: 3D BIOPRINTING MARKET, BY END USER, 2020–2028 (USD MILLION) 85

TABLE 79 FRANCE: 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2020–2028 (USD MILLION) 85

TABLE 80 FRANCE: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2028 (USD MILLION) 86

TABLE 81 FRANCE: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 86

TABLE 82 FRANCE: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATION BY TYPE, 2020–2028 (USD MILLION) 86

TABLE 83 FRANCE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2020–2028 (USD MILLION) 87

TABLE 84 FRANCE: 3D BIOPRINTING MARKET, BY END USER, 2020–2028 (USD MILLION) 87

TABLE 85 U.K: 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2020–2028 (USD MILLION) 88

TABLE 86 U.K: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2028 (USD MILLION) 88

TABLE 87 U.K: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 89

TABLE 88 U.K: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATION BY TYPE, 2020–2028 (USD MILLION) 89

TABLE 89 U.K: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2020–2028 (USD MILLION) 89

TABLE 90 U.K: 3D BIOPRINTING MARKET, BY END USER, 2020–2028 (USD MILLION) 90

TABLE 91 ITALY: 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2020–2028 (USD MILLION) 90

TABLE 92 ITALY: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2028 (USD MILLION) 91

TABLE 93 ITALY: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 91

TABLE 94 ITALY: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATION BY TYPE, 2020–2028 (USD MILLION) 91

TABLE 95 ITALY: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2020–2028 (USD MILLION) 92

TABLE 96 ITALY: 3D BIOPRINTING MARKET, BY END USER, 2020–2028 (USD MILLION) 92

TABLE 97 SPAIN: 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2020–2028 (USD MILLION) 93

TABLE 98 SPAIN: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2028 (USD MILLION) 93

TABLE 99 SPAIN: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 94

TABLE 100 SPAIN: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATION BY TYPE, 2020–2028 (USD MILLION) 94

TABLE 101 SPAIN: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2020–2028 (USD MILLION) 94

TABLE 102 SPAIN: 3D BIOPRINTING MARKET, BY END USER, 2020–2028 (USD MILLION) 95

TABLE 103 REST OF WESTERN EUROPE: 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2020–2028 (USD MILLION) 95

TABLE 104 REST OF WESTERN EUROPE: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2028 (USD MILLION) 96

TABLE 105 REST OF WESTERN EUROPE: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 96

TABLE 106 REST OF WESTERN EUROPE: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATION BY TYPE, 2020–2028 (USD MILLION) 97

TABLE 107 REST OF WESTERN EUROPE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2020–2028 (USD MILLION) 97

TABLE 108 REST OF WESTERN EUROPE: 3D BIOPRINTING MARKET, BY END USER, 2020–2028 (USD MILLION) 98

TABLE 109 EASTERN EUROPE: 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2020–2028 (USD MILLION) 98

TABLE 110 EASTERN EUROPE: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2028 (USD MILLION) 99

TABLE 111 EASTERN EUROPE: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 99

TABLE 112 EASTERN EUROPE: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATION BY TYPE, 2020–2028 (USD MILLION) 99

TABLE 113 EASTERN EUROPE: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2020–2028 (USD MILLION) 100

TABLE 114 EASTERN EUROPE: 3D BIOPRINTING MARKET, BY END USER, 2020–2028 (USD MILLION) 100

TABLE 115 ASIA-PACIFIC: 3D BIOPRINTING MARKET, BY COUNTRY, 2020–2028 (USD MILLION) 102

TABLE 116 ASIA-PACIFIC: 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2020–2028 (USD MILLION) 102

TABLE 117 ASIA-PACIFIC: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2028 (USD MILLION) 103

TABLE 118 ASIA-PACIFIC: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 103

TABLE 119 ASIA-PACIFIC: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATION BY TYPE, 2020–2028 (USD MILLION) 103

TABLE 120 ASIA-PACIFIC: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2020–2028 (USD MILLION) 104

TABLE 121 ASIA-PACIFIC: 3D BIOPRINTING MARKET, BY END USER, 2020–2028 (USD MILLION) 104

TABLE 122 JAPAN: 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2020–2028 (USD MILLION) 105

TABLE 123 JAPAN: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2028 (USD MILLION) 105

TABLE 124 JAPAN: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 106

TABLE 125 JAPAN: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATION BY TYPE, 2020–2028 (USD MILLION) 106

TABLE 126 JAPAN: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2020–2028 (USD MILLION) 106

TABLE 127 JAPAN: 3D BIOPRINTING MARKET, BY END USER, 2020–2028 (USD MILLION) 107

TABLE 128 CHINA: 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2020–2028 (USD MILLION) 108

TABLE 129 CHINA: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2028 (USD MILLION) 108

TABLE 130 CHINA: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 109

TABLE 131 CHINA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATION BY TYPE, 2020–2028 (USD MILLION) 109

TABLE 132 CHINA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2020–2028 (USD MILLION) 109

TABLE 133 CHINA: 3D BIOPRINTING MARKET, BY END USER, 2020–2028 (USD MILLION) 110

TABLE 134 INDIA: 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2020–2028 (USD MILLION) 111

TABLE 135 INDIA: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2028 (USD MILLION) 111

TABLE 136 INDIA: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 112

TABLE 137 INDIA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATION BY TYPE, 2020–2028 (USD MILLION) 112

TABLE 138 INDIA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2020–2028 (USD MILLION) 112

TABLE 139 INDIA: 3D BIOPRINTING MARKET, BY END USER, 2020–2028 (USD MILLION) 113

TABLE 140 AUSTRALIA: 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2020–2028 (USD MILLION) 114

TABLE 141 AUSTRALIA: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2028 (USD MILLION) 114

TABLE 142 AUSTRALIA: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 115

TABLE 143 AUSTRALIA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATION BY TYPE, 2020–2028 (USD MILLION) 115

TABLE 144 AUSTRALIA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2020–2028 (USD MILLION) 115

TABLE 145 AUSTRALIA: 3D BIOPRINTING MARKET, BY END USER, 2020–2028 (USD MILLION) 116

TABLE 146 SOUTH KOREA: 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2020–2028 (USD MILLION) 116

TABLE 147 SOUTH KOREA: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2028 (USD MILLION) 117

TABLE 148 SOUTH KOREA: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 117

TABLE 149 SOUTH KOREA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATION BY TYPE, 2020–2028 (USD MILLION) 117

TABLE 150 SOUTH KOREA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2020–2028 (USD MILLION) 118

TABLE 151 SOUTH KOREA: 3D BIOPRINTING MARKET, BY END USER, 2020–2028 (USD MILLION) 118

TABLE 152 REST OF ASIA–PACIFIC: 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2020–2028 (USD MILLION) 119

TABLE 153 REST OF ASIA–PACIFIC: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2028 (USD MILLION) 119

TABLE 154 REST OF ASIA–PACIFIC: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 120

TABLE 155 REST OF ASIA–PACIFIC: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATION BY TYPE, 2020–2028 (USD MILLION) 120

TABLE 156 REST OF ASIA–PACIFIC: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2020–2028 (USD MILLION) 120

TABLE 157 REST OF ASIA–PACIFIC: 3D BIOPRINTING MARKET, BY END USER, 2020–2028 (USD MILLION) 121

TABLE 158 MIDDLE EAST AND AFRICA: 3D BIOPRINTING MARKET, BY REGION, 2020–2028 (USD MILLION) 122

TABLE 159 MIDDLE EAST AND AFRICA: 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2020–2028 (USD MILLION) 123

TABLE 160 MIDDLE EAST AND AFRICA: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2028 (USD MILLION) 123

TABLE 161 MIDDLE EAST AND AFRICA: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 124

TABLE 162 MIDDLE EAST AND AFRICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATION BY TYPE, 2020–2028 (USD MILLION) 124

TABLE 163 MIDDLE EAST AND AFRICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2020–2028 (USD MILLION) 124

TABLE 164 MIDDLE EAST AND AFRICA: 3D BIOPRINTING MARKET, BY END USER, 2020–2028 (USD MILLION) 125

TABLE 165 MIDDLE EAST: 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2020–2028 (USD MILLION) 126

TABLE 166 MIDDLE EAST: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2028 (USD MILLION) 126

TABLE 167 MIDDLE EAST: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 127

TABLE 168 MIDDLE EAST: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATION BY TYPE, 2020–2028 (USD MILLION) 127

TABLE 169 MIDDLE EAST: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2020–2028 (USD MILLION) 127

TABLE 170 MIDDLE EAST: 3D BIOPRINTING MARKET, BY END USER, 2020–2028 (USD MILLION) 128

TABLE 171 AFRICA: 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2020–2028 (USD MILLION) 129

TABLE 172 AFRICA: 3D BIOPRINTING MARKET, BY MATERIAL, 2020–2028 (USD MILLION) 129

TABLE 173 AFRICA: 3D BIOPRINTING MARKET, BY APPLICATION, 2020–2028 (USD MILLION) 130

TABLE 174 AFRICA: 3D BIOPRINTING MARKET FOR RESEARCH APPLICATION BY TYPE, 2020–2028 (USD MILLION) 130

TABLE 175 AFRICA: 3D BIOPRINTING MARKET FOR CLINICAL APPLICATIONS BY TYPE, 2020–2028 (USD MILLION) 130

TABLE 176 AFRICA: 3D BIOPRINTING MARKET, BY END USER, 2020–2028 (USD MILLION) 131

16 List of Figures

FIGURE 1 RESEARCH PROCESS 21

FIGURE 2 TOP-DOWN & BOTTOM-UP APPROACH 26

FIGURE 3 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL 3D BIOPRINTING MARKET 28

FIGURE 4 PORTER’S FIVE FORCES ANALYSIS: GLOBAL 3D BIOPRINTING MARKET 32

FIGURE 5 SUPPLY CHAIN: GLOBAL 3D BIOPRINTING MARKET 34

FIGURE 6 GLOBAL 3D BIOPRINTING MARKET SHARE, BY TECHNOLOGY, 2020 (%) 37

FIGURE 7 GLOBAL 3D BIOPRINTING MARKET, BY TECHNOLOGY, 2020 & 2028 (USD MILLION) 37

FIGURE 8 GLOBAL 3D BIOPRINTING MARKET SHARE, BY MATERIAL, 2020 (%) 42

FIGURE 9 GLOBAL 3D BIOPRINTING MARKET, BY MATERIAL, 2020 & 2028 (USD MILLION) 42

FIGURE 10 GLOBAL 3D BIOPRINTING MARKET SHARE, BY APPLICATION, 2020 (%) 47

FIGURE 11 GLOBAL 3D BIOPRINTING MARKET, BY APPLICATION, 2020 & 2028 (USD MILLION) 47

FIGURE 12 GLOBAL 3D BIOPRINTING MARKET SHARE, BY END USER, 2020 (%) 54

FIGURE 13 GLOBAL 3D BIOPRINTING MARKET, BY END USER, 2020 & 2028 (USD MILLION) 54

FIGURE 14 GLOBAL 3D BIOPRINTING MARKET, BY REGION, 2020 & 2028 (USD MILLION) 58

FIGURE 15 GLOBAL 3D BIOPRINTING MARKET SHARE, BY REGION, 2020 (%) 59

FIGURE 16 AMERICAS: 3D BIOPRINTING MARKET SHARE, BY REGION, 2020 (%) 60

FIGURE 17 NORTH AMERICA: 3D BIOPRINTING MARKET SHARE, BY COUNTRY, 2020 (%) 63

FIGURE 18 EUROPE: 3D BIOPRINTING MARKET SHARE, BY REGION, 2020 (%) 75

FIGURE 19 WESTERN EUROPE: 3D BIOPRINTING MARKET SHARE, BY COUNTRY, 2020 (%) 79

FIGURE 20 ASIA-PACIFIC: 3D BIOPRINTING MARKET SHARE, BY COUNTRY, 2020 (%) 101

FIGURE 21 MIDDLE EAST AND AFRICA: 3D BIOPRINTING MARKET SHARE, BY REGION, 2020 (%) 122

3D Bioprinting Market

The 3D Bioprinting Market during the forecast period 2021to 2028, will register growth at a CAGR of 15.5%. The market for 3D bioprinting is set to reach US$ 4.3 Billion by 2028

Segmentation

By Technology Microextrusion Bioprinting Inkjet 3 D Bioprinting Laser Assisted Bioprinting Magnetic 3 D Bioprinting
By Material Living Cells Hydrogels Extracellular Matrices
By Application Research Applications Clinical Applications
By End-user Pharmaceutical & Biotechnology Companies Research Organizations & Academic Institutes

Key Players

  • Organovo Holdings Inc. (US)
  • ROKIT Healthcare (South Korea)
  • Cyfuse Biomedical K.K. (Japan)
  • CELLINK (Sweden)
  • EnvisionTEC GmbH (Germany)
  • Allevi Inc. (US)
  • Aspect Biosystems Ltd. (Canada)

Drivers

  • Growing Demand for Organ Transplantation
  • Cost-Efficiency of 3D Bioprinting
  • Increasing Funding and Investments for Research
Speak to Analyst Request a Free Sample

3D Bioprinting Market Overview


The 3D bioprinting market share is expected to undergo major enhancements for the current forecast period of 2021-2028. Owing to the market development and technological advancements, the market share is expected to reach USD 4.3 Billion by 2028 at a CAGR of 15.5%.


The advancement and degree of digitization in 3D biomaterials and bioprinting is increasing at a high scale in the cosmetology and pharmaceutical industry and this factor is being backed by the rise of the availability of funds for the public and private sector. Also, the rising support for bioprinting research activities is on the roll that promises good growth for the 3D bioprinting during the upcoming years.


COVID 19 Analysis


The novel coronavirus was reported in November 2019 in China and its arrival has changed the face of normal living ever since. The pandemic has introduced new trends for people to continue living their life and also, brought a major change for businesses and their functioning to meet the propelling demand of the target audience that is spread in various global locations. The businesses are witnessing a major issue in meeting the demand of the target audience and hence, the 3D bioprinting market segments in various global regions are struggling, too. This is because there is a lack of the availability of skilled labor and further, there is no or very little raw material available. The absence of these is a major problem in keeping up with the production trends. The pandemic is spreading at an obnoxious rate and hence, the people are changing their preferences that have an effect on their lifestyle, as well.


However, the governments are considering the rate of the spread and also, coming to terms with the fact that deep measures are required for the development of measures that will help in reviving the demand and bringing stability. The market players are considering the rise of the 3D printing market trend and hence, developing, products, services, and solutions that promise positive attributes to the market operations during the forecast period of 2021-2028.


3D Bioprinting Market Dynamics


Drivers


The technology related to 3D bioprinting has been witnessing a huge rate of adoption in the recent past and mainly in the healthcare industry. Bioprinting has witnessed a huge momentum in the form of a promising technology for its relation with the ability of tissue fabrication for artificial tissues and organs. This is all set to revolutionize the world of diagnosis and help in the treatment of many kinds of medical conditions. Companies across the world are soaring high on innovation and creativity that will help in coming up with regenerative medicine along with their concept solutions related to tissue engineering, stem cell therapies, alongside drug therapies.


Restraints 


The concept is an emerging field in the healthcare industry and is subject to constant development and advancements. This is generating a huge demand for the deployment of skilled professionals who have the expertise and are efficient enough to operate the 3D printing systems. The effective use of this technology demands a continuous process of monitoring which is only possible with an expert. However, the expert finding is a tedious task that is likely to hamper the growth of the 3D bioprinting market operations during the ongoing forecast period. 


Technology Analysis


There has been an increase in the stem cell research activities conducted and the financial support that is pouring from various organizations is one of the major advancements that is pushing for the regenerative medicine demand and the overall industry in various parts across the globe. The developing countries are on their way to making a supportive and regulatory environment available that supports the presence of larger product pipelines and applications related to medicine availability to treat diseases are some of the factors that will benefit the audience and help in expanding the 3D bioprinting market operations.


Study Objectives



  • To analyze the trends that are prevalent in the global market regions and players that will dominate the global trends and lead the market operations towards growth figures that have been predicted by the prominent leaders in the international market and key experts for the ongoing forecast period that ends in 2028.

  • To understand the scale of functioning of the global market segments that are prevalent through their ability to meet the vibrant needs of the target audience for market products and services in major mushrooming regions across the globe for the period.

  • To draw a competitive scale amongst the global market players producing the 3D bioprinting market solutions that are producing market products and solutions to render a huge degree of sales and also, understand the recent developments of the key market players in the recent past that promise great results to the market for the ongoing forecast period and market trends that ends in 2028.


3D Bioprinting Market Segment Overview


The 3D bioprinting of tissues and organs is prominent in major regions in the form of market segments. The market segments are as follows:


Based on the components


The 3D bioprinting market components are 3D bioprinters and bioinks which are further divided into inkjet 3d bioprinting, hybrid bioinks, magnetic 3D bioprinting, and synthetic bioinks, amongst others.


Based on the application


The 3D bioprinting market applications are drug research, 3D cell structure, medicine, and clinical application.


Based on material


The 3D bioprinting market materials include extracellular matrices, living cells, hydrogels, and other biomaterials.


3D Bioprinting Market Regional Analysis


Based on the 3D bioprinting industry analysis, the APAC region is expected to undergo the maximum demand and lead the market operations by attaining a global CAGR of 23.1%. The market is witnessing a high adoption rate of stem cell research in several regional markets that are providing opportunities and growth ideas for the market players. Also, government support is rising that will help the region to take a step forward towards competing in the international market.


3D Bioprinting Market Competitive Landscape


Based on the marketability to meet the rising global demand and the recent developments undertaken at a competitive rate, the market operations include the efforts of the following market players:



  • Organovo Holdings, Inc. (US)

  • ROKIT Healthcare (South Korea)

  • Cyfuse Biomedical K.K. (Japan)

  • CELLINK (Sweden)

  • EnvisionTEC GmbH (Germany)

  • Allevi Inc. (US)

  • Aspect Biosystems Ltd. (Canada)


Recent Developments



  • CELLINK SKIN and LIVER kit were launched in 2019. These kits have been designed in a way to provide quality information about the phenotype of their model tissues and this is further, helpful in conducting various researches for the further development of tissues useful in drug screening, and cosmetic testing. Digilab signed a collaborative agreement with a US-based firm namely Orgensis, Inc. in 2019. The main idea behind this collaboration was the development of live-cell printing processes and systems that will help in the automation of products that support both the 3-D live cellular tissues and structures.

  • In the same year, another prominent market player - Allevi came forward and took the international scale to launch a skin product that helps in producing various kinds of skin patches.

  • Organovo also entered into a collaboration with an Australian Institute and Netherlands’ Leiden University for the development and expansion of using the 3-D stem cells that have an important role to play when it comes to the treatment of renal diseases that are at the end-stage. This development was also done in 2019 and is helpful for the parent company to create a niche for its products in international competition.


3D Bioprinting Market Report Overview


The global market report aims to develop a deep understanding of the 3D bioprinting market potential and hence, tries to get the market insights and predict the growth rate of the market and the attainable market revenue during the forecast period. The report covers the following aspects in detail:



  • Market overview

  • COVID 19 Analysis

  • Market dynamics

  • Technology analysis

  • Market segmentation

  • Regional analysis

  • Competitive landscape

  • Recent developments


The global report discusses the potential of the market segments to keep up the demand of the market in various regions like the US, Canada, Mexico, India, Japan, Russia, Thailand, and South Korea, amongst others. The report also highlights the market trends in major global regions that will help the players and the competitive players in those regions dominate the global growth of the market by the end of the forecast period in 2028. Also, the report discusses the attempts undertaken by the market players and regions to enlarge their market size and strive for a better demand quantum.



Report Scope:
Report Attribute/Metric Details
  Market Size   2028: USD 4.3 Billion
  CAGR   15.5% (2021-2028)
  Base Year   2019
  Forecast Period   2020-2028
  Historical Data   2018
  Forecast Units   Value (USD Billion)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Technology, Material, Application, and End-user
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   REGENHU Ltd. (Switzerland), Nano3D Biosciences Inc. (U.S.), FUJIFILM Wako Automation Corporation (U.S.), Organovo Holdings Inc. (U.S.), Allevi (U.S.), Regenovo Biotechnology Co. Ltd. (China), Stratasys Ltd. (U.S.), Aspect Biosystems Ltd. (Canada), Poietis (France), EnvisionTEC GmbH (Germany), Cellink AB (Sweden), Cyfuse Biomedical K.K. (Japan)
  Key Market Opportunities   Growing Application of 3D Bioprinting in Cosmetic Industry
  Key Market Drivers   Growing Demand for Organ Transplantation


Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

3D bioprinting encompasses an array of 3D printing methods to combine cells and biomaterials to produce biomedical parts. Although the technology is in high use for research and development purposes, its application in the production of tissues and organs is likely to garner high demand.

The 3D Bioprinting Market is predicted to touch USD 4.3 Billion by 2028.

The 3D Bioprinting Market is projected to grow at a 15.5% CAGR between 2021-2028.

The Americas are projected to have a major share in the 3D Bioprinting Market.

Growing demand for organ transplantation is Boosting Market growth.

Lack of skilled professionals and lack of awareness may limit market growth.